Cidara Therapeutics, Inc. (CDTX): Price and Financial Metrics
CDTX Price/Volume Stats
| Current price | $21.70 | 52-week high | $28.42 |
| Prev. close | $21.25 | 52-week low | $10.00 |
| Day low | $20.76 | Volume | 229,200 |
| Day high | $22.00 | Avg. volume | 148,327 |
| 50-day MA | $20.33 | Dividend yield | N/A |
| 200-day MA | $14.46 | Market Cap | 152.92M |
CDTX Stock Price Chart Interactive Chart >
Cidara Therapeutics, Inc. (CDTX) Company Bio
Cidara Therapeutics, Inc. focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in June 2014. The company was founded in 2012 and is based in San Diego, California.
CDTX Price Returns
| 1-mo | -6.55% |
| 3-mo | 92.04% |
| 6-mo | 81.59% |
| 1-year | 51.77% |
| 3-year | 31.20% |
| 5-year | -69.26% |
| YTD | -19.27% |
| 2024 | 69.27% |
| 2023 | 4.98% |
| 2022 | -40.45% |
| 2021 | -36.50% |
| 2020 | -47.92% |
Loading social stream, please wait...